<!DOCTYPE html>
<html lang="en" ng-app="">
  <head>
    <title> </title>
    <link rel="shortcut icon" href="css/images/?.ico" type="image/x-icon">
    <!--style-->
    <link rel="stylesheet" href="libraries/font-awesome/css/font-awesome.min.css">
    <link rel="stylesheet" type="text/css" href="libraries/bootstrap/dist/css/bootstrap.min.css">
    <link rel="stylesheet" href="css/main.css">
    <!-- libraries -->
    <script src="libraries/echarts/build/dist/echarts.js"></script>
    <script src="libraries/jquery/jquery.min.js"></script>
    <script src="versioned/jquery-ui.min.js"></script>
    <script src="libraries/underscore/underscore-min.js"></script>
  </head>
  <body ng-controller=""><img src="css/img/legend.png" class="legend">
    <div id="dView" class="detail-view"><a id="close" class="btn"><i class="fa fa-times"></i></a>
      <div id="dynamic">
        <div>
          <div>NeuroLINCS</div>
          <div>xyz</div>
          <div>dafda</div>
        </div>
      </div>
    </div>
    <div id="main" style="height:800px;padding:10px;"></div>
    <div class="container">
      <div class="header"><span>Entires not included</span></div>
      <div class="content">
        <div> <span class="center2">DTOXS</span>    (reason: cell-lines not sure)
          <ul>
            <li>RNASeq.Cardiomyocyte "Efficacy/Toxicity Ratio" Joint project- Collaborators: ISMMS, UCI, HMS, Broad/Golub, Broad/Jaffe, OHSU & DCIC*</li>
            <li>Proteomics.Cardiomyocyte "Efficacy/Toxicity Ratio" Joint project- Collaborators: ISMMS, UCI, HMS, Broad/Golub, Broad/Jaffe, OHSU & DCIC*</li>
            <li>Western blots/PCR (validation assays).Cardiomyocyte "Efficacy/Toxicity Ratio" Joint project- Collaborators: ISMMS, UCI, HMS, Broad/Golub, Broad/Jaffe, OHSU & DCIC*</li>
          </ul>
        </div>
        <div> <span class="center2">LINCS-HMS </span>   (reason: perturbations not sure)
          <ul>
            <li>LJP5&6-growth inhibition/drug combitions: Sensitivity measures of 6 breast cancer cell lines to combition treatment of kinase inhibitors based on results of  dataset LJP5&6-growth inhibition/single drugs</li>
            <li>LJP5&6-L1000/drug combitions: L1000 response of 6 breast cancer cell lines to treatment plates LJP7-9 (177 targeted drugs). Complement  to dataset LJP5&6-L1000/single drugs</li>
          </ul>
        </div>
        <div> <span class="center2">NeuroLINCS </span>   (reason: perturbations not sure, QC entry)
          <ul>
            <li>RNASeq for control and diseased iMNs plus perturbations</li>
            <li>QC and SOP development for proteomic alysis  iPSC to  motor neuron differentiation</li>
            <li>Quantitative discovery proteomics (SWATH), add perturbagens</li>
            <li>Epigenomics-ATAC-Seq for control and disease iMNs plus perturbations</li>
          </ul>
        </div>
      </div>
    </div>
    <div style="display:none">The following Milestone entries are not included because of missing information (mostly perturbations are not specified):
      <ul>
        <li>LINCS.ISMMS.Iyengar.Milestone.RNASeq.Cardiomyocyte "Efficacy/Toxicity Ratio" Joint project- Collaborators: ISMMS, UCI, HMS, Broad/Golub, Broad/Jaffe, OHSU & DCIC*</li>
        <li>LINCS.ISMMS.Iyengar.Milestone.Proteomics.Cardiomyocyte "Efficacy/Toxicity Ratio" Joint project- Collaborators: ISMMS, UCI, HMS, Broad/Golub, Broad/Jaffe, OHSU & DCIC*</li>
        <li>LINCS.ISMMS.Iyengar.Milestone.Western blots/PCR (validation assays).Cardiomyocyte "Efficacy/Toxicity Ratio" Joint project- Collaborators: ISMMS, UCI, HMS, Broad/Golub, Broad/Jaffe, OHSU & DCIC*</li>
        <li>LINCS.HMS.Sorger.Milestone.LJP5&6-growth inhibition/drug combitions: Sensitivity measures of 6 breast cancer cell lines to combition treatment of kinase inhibitors based on results of  dataset LJP5&6-growth inhibition/single drugs</li>
        <li>LINCS.HMS.Sorger.Milestone.LJP5&6-L1000/drug combitions: L1000 response of 6 breast cancer cell lines to treatment plates LJP7-9 (177 targeted drugs). Complement  to dataset LJP5&6-L1000/single drugs</li>
        <li>LINCS.NeuroLINCS.Thompson.RNASeq for control and diseased iMNs plus perturbations</li>
        <li>LINCS.NeuroLINCS.Thompson.QC and SOP development for proteomic alysis  iPSC to  motor neuron differentiation</li>
        <li>LINCS.NeuroLINCS.Thompson.Quantitative discovery proteomics (SWATH), add perturbagens</li>
        <li>LINCS.NeuroLINCS.Thompson.Epigenomics-ATAC-Seq for control and disease iMNs plus perturbations</li>
      </ul>
    </div>
  </body>
  <script src="dist/main.min.js"></script>
</html>